Navigation Links
Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology
Date:12/17/2007

EDMONTON, Dec. 17 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (TSX Venture Exchange: QPT) today announced that it has signed an agreement with a multinational technology development company (the "Investor") to receive $3,000,000 to develop oncology products based on its SonoLight Technology. Under the terms of the agreement, Quest Pharma Tech Inc. ("Quest" or the "Company") has already received $1,000,000; and the balance of $2,000,000 will be paid within the next twelve months. In return for this non-equity funding, the Investor who requested to remain anonymous, will receive 35 percent of all future net revenue from the commercialization of Quest's oncology products. This agreement does not preclude Quest from out-licensing the oncology applications of SonoLight Technology to a third party.

The Company's lead oncology product from the SonoLight platform, SL052, is anticipated to enter a Phase I clinical trial for photodynamic therapy treatment of prostate cancer during the second half of 2008. The Company is also evaluating the same technology for the treatment of lung cancer and peritoneal carcinomatosis.

"I can't think of a better holiday present to our shareholders than establishing an accelerated oncology development program," said Dr. Madi R. Madiyalakan, Chief Executive Officer of Quest Pharma Tech Inc. "We are optimistic about the potential of both our oncology products and our dermatology program. Additionally, we believe that our partnerships with Paramount BioSciences and KMH Co. Ltd. will help us achieve our long-term growth objectives, including share price appreciation."

About Quest PharmaTech Inc.

The Corporation is a publicly traded (TSX Venture Exchange: QPT), Alberta-based pharmaceutical company committed to build shareholder value through discovery, development, and commercialization of new pharmaceutical products. It is developing a series of products for the treatment of cancer and dermatological conditions
'/>"/>

SOURCE Quest PharmaTech Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. ImmuneRegen Responds to Defense Threat Reduction Agency Request for Information
2. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
3. Quest Diagnostics to Speak at the 2007 UBS Global Life Sciences Conference
4. VioQuest Pharmaceuticals to Present at BIO InvestorForum in San Francisco
5. Quest Diagnostics Joins National ePrescribing Patient Safety Initiative (NEPSI)
6. University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement
7. VioQuest Pharmaceuticals to Present at the Paramount BioSciences Healthcare Conference
8. Sinovac Requests Extension for Annual Shareholders Meeting
9. Maryland Stem Cell Commission Issues Nationwide Request for Applications for New Post-Doctoral Fellowship Grants
10. AmSurg Selects SciQuest Eprocurement Solution to Automate Purchasing of Medical Goods and Services
11. WuXi PharmaTech Schedules 2007 Second Quarter Earnings Release on Thursday, September 6, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/15/2014)... 2014 Algenol Biofuels will present at CleanEquity Monaco ... of Monaco . Logo - ... annual invitation-only event hosted by Innovator Capital, the ... partners and sponsors include Prince Albert II of ... University, PR Newswire, the Monte-Carlo SBM, Oceanographic Museum of ...
(Date:11/15/2014)... Calif. , Nov. 14, 2014  F. ... by Continental Who,s Who as a Pinnacle Professional in ... role as President of Cell Point, LLC. ... offices in Centennial, Colorado , ... . The company,s five technology platforms, ethylenedicysteine drug ...
(Date:11/12/2014)... -- ReachBio Research Labs (a registered trade name of ReachBio ... that it has signed an agreement with Funakoshi Co., ... non-exclusive distribution rights to ReachBio,s human primary cell product ... Japan . Under a companion agreement, Funakoshi ... Japanese drug development companies. Photo - ...
(Date:11/12/2014)... (PRWEB) November 11, 2014 ... and one year of achieving GMP compliance with ... clearly defined and impressive blueprint for creating high ... and Requisition process and ending with the final ... where each product is in the process,” explains ...
Breaking Biology Technology:Algenol Biofuels Selected to Present at CleanEquity Monaco 2015 2F. David Rollo, MD, Ph.D., FACC, FACNP is recognized by Continental Who's Who as a Pinnacle Professional 2Funakoshi to Distribute ReachBio Research Labs Human Primary Cell Products in Japan 2Funakoshi to Distribute ReachBio Research Labs Human Primary Cell Products in Japan 3Innovative Formulations Achieves GMP Compliance and Success with InstantGMP™ MES 2
... 20 /PRNewswire-Asia/ -- Sundia MediTech Company, a leading,pharmaceutical ... that,the company was named as a Top 100 ... by China Council for International,Investment Promotion (CCIIP) and ... This ranking covers outsourcing services in IT,pharmaceutical, ...
... ... 7 of the Top 10 pharmaceutical and 3 of the Top 5 medical device companies. ... Charlottesville, VA, San Diego, ... provider of technology and information solutions for the life sciences industry announced today a continuing ...
... , , , SAN ... VIAP ), a biotechnology company focused on the development of ... announced that it received a Staff Determination letter, dated July ... Company has not regained compliance with the minimum $2,500,000 stockholders, ...
Cached Biology Technology:OpenQ Posts a 200% Revenue Growth in the First Half of 2009 2VIA Pharmaceuticals Receives Anticipated Notice From NASDAQ 2VIA Pharmaceuticals Receives Anticipated Notice From NASDAQ 3VIA Pharmaceuticals Receives Anticipated Notice From NASDAQ 4
(Date:11/5/2014)... has dedicated his career to understanding the Earth,s ... audience. , As deputy director and regional climatologist ... Desert Research Institute, Redmond has more than three ... dissemination of climate data to the general public. ... San Francisco on December 15-19, 2014 the American ...
(Date:11/4/2014)... School of Medicine announced today that it is ... by the Bill & Melinda Gates Foundation. ... and Reproductive Sciences; and Vice Chair of Research ... Medicine will pursue an innovative global health and ... Assess Fetal Neurodevelopment.", Grand Challenges Explorations (GCE) funds ...
(Date:11/4/2014)... – (Nov. 4, 2014) – A majority of Madagascar,s ... that could have serious consequences for the rainforests they ... shows the positive impacts lemurs can have on rainforest ... their disappearance could have on the region,s rich biodiversity. ... have fruits eaten by lemurs. Lemurs in turn ...
Breaking Biology News(10 mins):Nevada climatologist to be honored at AGU Fall Meeting for lifetime of public outreach 2Temple University School of Medicine receives Grand Challenges Explorations grant 2Gardeners of Madagascar rainforest at risk 2Gardeners of Madagascar rainforest at risk 3
... Thirteen UC Riverside researchers have been named fellows of ... Including this years fellows, the total number of UCR ... distinction is 172., Election as a fellow is an ... year AAAS gave this honor to 486 of its ...
... strength along the California coast may have far-reaching effects, ... coast early in the season and increased fire danger ... Change and Impacts Laboratory at the University of California, ... present the findings in a poster titled "Future Changes ...
... The initial results of the first computer model ... representation of individual clouds have been analyzed by ... Research Center (IPRC) at the University of Hawai`i ... Technology (JAMSTEC), and the University of Tokyo. ...
Cached Biology News:13 UCR faculty members recognized by American Association for the Advancement of Science 213 UCR faculty members recognized by American Association for the Advancement of Science 3Stronger coastal winds due to climate change may have far-reaching effects 2
... 10X PCR Enhancer (with betaine) substantially ... sensitivity and specificity for amplification of ... Enhancer in PCR eliminates the base-pair ... enzyme?s thermal stability, suppresses pauses of ...
... provide rapid, precise localization of cell ... or paraffin-embedded tissue, cytospins and touch ... double or triple labeleing experiments, as ... primary antibodies of different animal species. ...
... HistoMark Biotin Streptavidin-HRP Systems provide rapid, ... intracellular antigens in frozen or paraffin-embedded ... These systems also facilitate double or ... be performed simultaneously with primary antibodies ...
... covers can be used with ... covers for stacking of covered ... for use with automated systems ... and non-ridged, are available for ...
Biology Products: